TRPV1 and Hepatic fibrosis: Taken together, our findings suggested a pathological role of TRPV1 in the development of CCl4-induced hepatic fibrosis, as well as the activation and proliferation of HSC, implying that TRPV1 might be a promising therapeutic target for developing antifibrosis strategies with improved outcomes.